Early results presented at a cancer research conference showed tumor shrinkage and slowed disease progression in patients who ...
MedPage Today on MSN
Early Lung Cancer Data Show Why FDA Approved HER2 Agent in First-Line
Zongertinib in phase I trial showed sustained efficacy in aggressive disease ...
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients ...
The 84-year-old Navy veteran, whose real name is Kenny Jary, boasts over 4 million followers across social media platforms ...
Most people think that lung cancer is a disease that only happens to people who smoke. But cardiothoracic and vascular ...
Leah Phillips, a Kentucky mom of three, said she was initially told her symptoms were due to a cold, allergies or anxiety ...
Boehringer Ingelheim today announced that The New England Journal of Medicine (NEJM) published results from the Phase 1b Beamion LUNG-1 trial of HERNEXEOS (zongertinib tablets) in ...
Dr Christine Bestvina discusses EGFR treatment shifts, KRAS trial data, and expanding clinical trial access for community oncologists. Lung cancer treatment has undergone a remarkable transformation ...
The American Lung Association in New York is inviting the New York City community to unite as one mighty force for lung ...
First-line zongertinib showed antitumor activity in treatment-naive patients with advanced or metastatic HER2-mutant ...
3don MSN
Dick Vitale Cancer: ESPN Legend Diagnosed With Fifth Cancer, Melanoma Found in Lung and Liver
ESPN’s Dick Vitale, 86, faces his fifth cancer as melanoma spreads to the lung and liver. He remains optimistic, highlighting ...
Lung cancer is the deadliest cancer—but early screening can save lives. A survivor’s story and expert insight show why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results